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Supplementary
General Chemistry Methods
Chemicals were purchased from Sigma-Aldrich, Acros, or Alfa Aesar and used without further purification. Anhydrous solvents from Sigma-Aldrich were used without further treatment.
Diethylphosphonoacetic acid (4) was obtained from Sigma-Aldrich and methylenebisphonic acid triethyl ester (8) was synthesised from
[ethyloxybenzyloxyphosphorylmethyl]phosphonic acid diethyl ester 5 (see details below). TLC was performed on precoated plates (Merck Aluminum sheets silica 60 F254, art No. 5554).
Chromatograms were visualised under UV light and by dipping plates into either phosphomolybdic acid in EtOH or alkaline KMnO4 solution, followed by heating. Diol (-)-3 was synthesised in three steps from 2,4,6-tri-O-benzyl myo-inositol orthobenzoate (11) 6 . Regioselective reduction 7 of 11 using 3.5 equivalents of DIBAL-H gave racemic diol ()-
3.
To obtain the required enantiomer of 3, we applied a previously reported 8 optical resolution of this diol using regioselective formation of diastereoisomeric monocamphanate esters. Thus, reaction of ()-3 with 1.1 equivalents of (-)-(1S)-camphanic chloride in pyridine gave monocamphanate esters 12 and 13. Separation of these esters by flash chromatography and hydrolysis of the more polar ester 13, previously identified as the 1-O- 
Determination of Absolute Configurations of Monocamphanate Esters 12 and 13 D-1,2,4,6-tetra-O-benzyl-3-O-methyl-myo-inositol (14)
To a solution of the less polar monocamphanate 12 (200 mg, 0.277 mmol) in dry THF (4 mL) at 0 °C was added a strictly catalytic amount of PTSA (2 mg), followed by 2-methoxypropene (0.60 mL, 0.45 g, 6.2 mmol). After 10 min, the cooling bath was removed and the solution was allowed to reach room temperature over 1 hour. TLC (EtOAc:light petroleum 1:3)
showed conversion of 12 (Rf 0.36) into a less polar product (Rf 0.54). The solution was stirred at room temperature and a solution of LiOH.H2O (118 mg, 2.8 mmol) in deionised water (2 mL) and methanol (2 mL) was added. After 2 h, TLC (EtOAc:light petroleum 1:3) showed that S9 the camphanate ester had been cleaved, giving a slightly more polar product (Rf 0.40). The volatile solvents were removed by evaporation under reduced pressure, and then more deionised water (20 mL) was added, followed by dichloromethane (20 mL). The organic layer was separated and the aqueous layer was re-extracted with more dichloromethane (20 mL).
The combined organic layers were dried (MgSO4) and concentrated. The residue was redissolved in dry DMF (5 mL) and sodium hydride (110 mg of a 60% suspension in oil, 2.8 mmol) was added. The suspension was stirred at rt for 5 min, then cooled to 0 °C under N2.
Methyl iodide (137 μL, 2.2 mmol) was added dropwise and stirring was continued at 0 °C for a further 30 min before the cooling bath was removed and the solution was stirred at rt for a 
D-myo-inositol 1,5-di-O-(diethyloxyphosphorylacetate) (6)
To a solution of 5 (139 mg, 0.155 mmol) in MeOH (7 mL) and deionised water (1 mL) was added palladium hydroxide on activated charcoal (20%, 50% water, 70 mg). 
D-myo-inositol 2,3,4,6-tetrakis(dibenzylphosphate) 1,5-di-O-(diethyloxyphosphorylacetate) (7)
To a stirred suspension of 5-phenyltetrazole (98 mg, 0.672 mmol) in dry dichloromethane (2 mL) under N2 at room temperature was added bis(benzyloxy)diisopropylaminophosphine 
D-myo-inositol 2,3,4,6-tetrakisphosphate-1,5-bis-O-phosphorylacetate (1)
A stirred solution of 7 (115 mg, 73 μmole) in dry dichloromethane (2 mL) was cooled to 0 °C under N2 and trimethylsilyl bromide (1 mL) was added dropwise over 5 min. The solution was allowed to warm gradually to room temperature, and stirring was continued for 48 h.
The solution was concentrated and methanol (5 mL) was added to the residue. The resulting colourless solution was stirred at room temperature for a further 1 h, then concentrated to give a white gum. The gum was washed with diethyl ether (3  3 mL), then taken up in 1.0 moldm -3 TEAB (10 mL, pH 7.6) to give a cloudy suspension. This suspension was washed with diethyl ether (3  10 mL) to give a colourless, clear solution. This solution was concentrated under reduced pressure, re-dissolved in methanol and concentrated again. This cycle was repeated several times until a clear, colourless, glassy solid remained, which was finally redissolved in de-ionised water and lyophilised to give the triethylammonium salt of 1 as a brittle colourless solid (89 mg, 61 μmole, 84 %); [α]DS14 phosphate P), 0.12 (1 P, phosphate P), 11.60 (1 P, phosphonate P), 12.20 (1 P, phosphonate P); 31 P NMR (CD3OD, 162 MHz)  -0.67 (1 P, phosphate P), 0.43 (1 P, phosphate P), 0.55 (1 P, phosphate P), 1.12 (1 P, phosphate P), 11.60 (1 P, phosphonate P), 12. 
Methylenebisphosphonic acid triethyl ester (8)
To 
myo-inositol (9)
To a solution of 8 (670 mg, 2.58 mmol) in anhydrous toluene (4 mL) under N2 at 0 °C was added oxalyl chloride (0.9 mL, 10 mmol) followed by a catalytic amount of DMF (< 5μL). To a solution of 9 (74 mg, 0.072 mmol) in methanol (2 mL) and THF (2 mL) was added deionised water (0.5 mL), acetic acid ( 
